3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
11
Osteoporosis
5
Prostatic Neoplasms
4
Neoplasms
4
Multiple Myeloma
2
Unspecified Childhood Solid Tumor, Protocol Specific
1
Testicular Neoplasms
1
Smoldering Multiple Myeloma
1
Regional Osteoporosis as a Result of Chemotherapy
1
Recurrence
1
Polycystic Ovary Syndrome
1
Paraganglioma, Extra-Adrenal
1
Pain
1
Neoplasms, Plasma Cell
1
Myelodysplastic Syndromes
1
Monoclonal Gammopathy of Undetermined Significance
1
Metabolic Syndrome
1
Menstruation Disturbances
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lymphedema
1
Leukemia
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Depression
1
Cicatrix
1
Cardiovascular Diseases
1
Carcinoma, Transitional Cell
1
Interventions
Cisplatin
90
Fluorouracil
76
Radiotherapy
63
Paclitaxel
58
Docetaxel
49
Oxaliplatin
48
Irinotecan
42
Leucovorin
32
Capecitabine
31
Carboplatin
27
Radiation
21
Surgical Procedures, Operative
20
Esophagectomy
20
pembrolizumab
15
Neoadjuvant Therapy
15
Bevacizumab
15
Cetuximab
13
Drug Therapy
12
Epirubicin
11
Chemotherapy, Adjuvant
9
S 1 (combination)
8
Magnetic Resonance Spectroscopy
8
Gemcitabine
8
Trastuzumab
7
Nivolumab
7
Erlotinib Hydrochloride
7
Surveys and Questionnaires
6
Panitumumab
6
Immunohistochemistry
6
Chemoradiotherapy
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Esophageal Neoplasms
×
Absorptiometry, Photon
×
Clear all
NCT01742312
2016-02-18
Oeso-Chemo
University of Nottingham
Completed
25 enrolled